Streetbeat News

MRMD

MariMed Inc

Employees

326

Industry

Medicinal and Botanical Manufacturing

Open

0.16

Mkt cap

59M

Volume

18K

High

0.16

P/E Ratio

-5.17

52-wk high

0.39

Low

0.15

Div yield

N/A

52-wk low

0.14

Cannabis companies reported strong Q1'24 earnings, with significant EBITDA beats, yet analysts have been conservative in revising full-year estimates upwards. Despite the aggregate EBITDA beat of $37M, full-year estimates increased by only $14M, with cuts for six out of ten companies. This cautious approach follows a year of downward revisions in 2023, indicating a trend of analysts playing catch-up in a positive direction.

Portfolio Pulse from Viridian Capital Advisors

May 13, 2024 | 3:43 pm

Cannabis stocks experienced significant movements on May 9, 2024, with notable gainers including Global Hemp Group, MJ Holdings, and SOL Global Investments, among others. Conversely, Auxly Cannabis Group led the losers, followed by Elixinol Wellness and CordovaCann. The movements reflect the volatile nature of the cannabis market, with companies like Canopy Growth, Cronos Group, and Aurora Cannabis also seeing gains.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 8:30 pm

MeriMed, identified by its ticker MRMD, has projected its capital expenditures for fiscal year 2024 to be $10 million.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 10:18 pm

MariMed (OTC:MRMD) reported Q1 sales of $37.933M, surpassing the analyst consensus estimate of $36.950M by 2.66% and marking a 10.33% increase from the previous year's sales of $34.380M.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 9:25 pm

Marijuana stocks experienced significant movement with Target Group, Global Compliance, and Heritage Cannabis Holding among the top gainers, while Item 9 Labs and Global Hemp Group led the losers. Notable NASDAQ-listed companies like Psychemedics, SNDL, Genetic Technologies, Urban-gro, Village Farms Intl, Canopy Growth, and Greenlane Holdings also saw varied price changes.

Portfolio Pulse from Benzinga Insights

May 06, 2024 | 8:30 pm

Marijuana stocks experienced significant movements on May 1, 2024, with notable gainers including Global Hemp Group and 22nd Century Group, while losers featured AusCann Group Holdings and Canopy Growth among others. The shifts reflect volatile market conditions in the cannabis sector.

Portfolio Pulse from Benzinga Insights

May 01, 2024 | 8:30 pm

Marijuana stocks experienced significant movements with Elixinol Wellness, Item 9 Labs, and Canopy Growth among the top gainers, while Charlotte's Web Holdings and Pharmadrug led the losers. The market saw a bullish trend for cannabis companies, with notable increases in stock prices for many firms listed on both OTC and NASDAQ.

Portfolio Pulse from Benzinga Insights

April 30, 2024 | 8:30 pm

The DEA's decision to move cannabis from Schedule I to Schedule III under the Controlled Substances Act has been met with widespread approval from industry leaders. MariMed and Indoor Harvest Corp specifically expressed positive outlooks, highlighting the decision's potential to benefit consumers, patients, and the industry at large. The move is seen as a significant shift in drug policy, with implications for medical recognition, business operations, and global cannabis markets.

Portfolio Pulse from Rolando García

April 30, 2024 | 7:58 pm

Marijuana stocks experienced significant movement on April 25, 2024, with notable gainers including Cannabix Technologies, Kaya Holdings, and Urban-gro, among others. Conversely, several companies faced declines, such as Global Hemp Group, GrowGeneration, and Aurora Cannabis. This reflects the volatile nature of the marijuana stock market.

Portfolio Pulse from Benzinga Insights

April 25, 2024 | 8:30 pm

Cannabis stocks saw significant movement on April 22, 2024, with notable gainers including Affinor Growers, Elixinol Wellness, and Cannabix Technologies, among others. Conversely, Green Growth Brands led the losers, followed by Target Group and Greenlane Holdings. The movements reflect the volatile nature of the cannabis market.

Portfolio Pulse from Benzinga Insights

April 22, 2024 | 8:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.